Press Room

Press Room

Press release

The CEO of Duchesnay Pharmaceutical Groupe, Éric Gervais, shared his thoughts on the future of the life sciences industry with Investment Reports.

Read more >
Press release

Duchesnay Pharmaceutical Group opened its doors to a Ukrainian refugee last June.

Read more >
Press release

Duchesnay announces the launch of Vablys® (dequalinium chloride vaginal tablets), an antiseptic and anti-infective treatment for bacterial vaginosis

Read more >
Press release

Slynd® (drospirenone), a new progestin-only contraceptive pill from Duchesnay which offers a 24-hour safe window for a missed pill

Read more >
Press release

Duchesnay Pharmaceutical Group donates Quebec-made medicines and vitamins to Ukraine to help those affected by war

Read more >
Press release

Postmenopausal Canadian women experiencing vaginal dryness and painful intercourse have a new oral once-daily prescription treatment, Osphena® (ospemifene tablets) from Duchesnay

Read more >